Is it time to retire the Bag-Valve-Mask for preoxygenation?
Emergency intubation carries a notorious risk of life-threatening hypoxemia, yet the debate on the safest way to build an oxygen reserve continues . In this episode, we unpack a 2026 systematic review and meta-analysis that challenges the status quo, pitting Noninvasive Ventilation (NIV) directly against standard Bag-Valve-Mask (BVM) ventilation .
We dive into data from three randomized controlled trials involving over 1,500 critically ill adults . The verdict? NIV emerged as the clear winner for efficacy, significantly slashing the risk of hypoxemia during intubation compared to BVM . Perhaps even more importantly for the safety-conscious provider, the study busts a persistent myth: NIV demonstrated no significant difference in regurgitation rates compared to BVM, alleviating long-held fears about aspiration risk .
So, what does this mean for your next airway crash? This evidence suggests NIV offers a superior safety buffer for oxygenation without the feared trade-offs . Tune in as we explore why this procedural switch could be a game-changer for patient safety in the ED and ICU.